FONT-SIZE Plus   Neg

CryoPort Names Stephen Wasserman To Board - Quick Facts

CryoPort, Inc. (CYRX.OB) on Thursday said it has named Stephen Wasserman, 65, to its Board of Directors. He replaces Carlton Johnson, who resigned from the Board earlier this month.

CryoPort provides cold chain frozen shipping systems primarily to the biotechnology, pharmaceutical, and life science industries. Wasserman has over 30 years of senior operating and financial management experience in the medical device and healthcare industries.

Wasserman is currently on the Board of the medical diagnostics firm Iris International and serves as chairman of the compensation committee.

Previously he was group vice president of the Diagnostic Systems Products division of medical technology firm Olympus America as well as a member of the executive committee for American Operations.

Larry Stambaugh, CryoPort's chairman and chief executive officer, said, "Stephen's experience managing highly successful medical device and diagnostic companies will be extremely valuable to CryoPort as we accelerate our commercial activities this year. We look forward to drawing on Stephen's in-depth knowledge of our target markets and his proven ability to drive the introduction of new technologies and products."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
T-Mobile US Inc. on Monday lifted its forecast for fiscal 2016 adjusted EBITA, a key earnings metric, as well as customer additions after reporting a surge in third-quarter profit and and revenues with strong customer growth. Earnings per share came in above market estimates. In pre-market activity, shares were gaining around 4.8 percent to $49. Shares of Philips Electronics NV were gaining around 3 percent in the early morning trading in Amsterdam after the Dutch consumer electronics giant reported Monday a higher profit in its third quarter driven by margin strength with improved performance in its segments. Consolidated comparable sales growth was 2 percent, driven by 5 percent increase in HealthTech portfolio. AT&T announced a definitive agreement to purchase Time Warner in a stock-and-cash transaction valued at $107.50 per share. This purchase price implies a total equity value of $85.4 billion and a total transaction value of $108.7 billion, including Time Warner's net debt. AT&T expects the deal to close before year-end 2017.
comments powered by Disqus
Follow RTT